(Q44990813)

English

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

type 2 diabetes

0 references

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Nesto R

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

810-817

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Plaque disruption and thrombosis: potential role of inflammation and infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Insulin resistance affects endothelium-dependent acetylcholine-induced coronary artery response.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Antiinflammatory and antiarteriosclerotic effects of pioglitazone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Peroxisome proliferator-activated receptors in endothelial cell biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Rosiglitazone reduces urinary albumin excretion in type II diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Nuclear Factor- B Suppressive and Inhibitor- B Stimulatory Effects of Troglitazone in Obese Patients with Type 2 Diabetes: Evidence of an Antiinflammatory Action?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

TNFα expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01296.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2004.01296.X

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44990813&oldid=2060685567"